Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome

11 Oct 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24381414
DOI: 10.1007/s12291-012-0269-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward SyndromePMID 24381414Read ↗

First-trimester Down syndrome screening: Free β-human chorionic gonadotropin and pregnancy-associated plasma protein ASemantic proximity Read ↗

ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal AbnormalitiesSemantic proximity Read ↗

First trimester screening for aneuploidy: Serum biochemical markersSemantic proximity Read ↗

DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic ProceduresSemantic proximity Read ↗

Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinSemantic proximity Read ↗

Study of first-trimester serum levels of β-hCG and PAPP-A as a screening test for fetal development of intrauterine growth restrictionSemantic proximity Read ↗

Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screeningSemantic proximity Read ↗

Advances in prenatal screening for Down syndrome: I. General principles and second trimester testingSemantic proximity Read ↗

Does a “vanishing twin” affect first-trimester biochemistry in Down syndrome risk assessment?Semantic proximity Read ↗

The history of the second‐trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practiceSemantic proximity Read ↗

Distinctive pattern of first trimester maternal serum biochemical markers in trisomy 22 pregnanciesSemantic proximity Read ↗

Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.